COMP <GO>
OGN vs UNH // EV/EBITDA & P/E VALUATION
Organon & Co. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: OGN 4
— UNH 6
■ METRIC PARITY
LAST: $13.82 (-0.14%) • MKT CAP: $3.63B
valuation
—
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
valuation
15.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OGN VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OGN | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 53.30% | 88.31% | -35.01 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.90% | 12.38% | +12.52 | OGN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 14.83% | 6.25% | +8.58 | OGN | /fcf-yield <GO> |
| Operating Margin | — | 5.32% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 3.00% | 3.53% | -0.53 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -2.90% | 3.33% | -6.23 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.43% | 2.29% | +0.14 | OGN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.09 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.0 | 55.1 | +4.90 | OGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 17.7x | +0.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.63B | $359.43B | -$355.80B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OGN REV | UNH REV | OGN GROSS % | UNH GROSS % | OGN FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.22B | $447.57B | 53.3% | 88.7% | $538.0M | $16.07B |
| FY 2024 | $6.40B | $400.28B | 58.0% | 88.3% | $764.0M | $20.70B |
| FY 2023 | $6.26B | $371.62B | — | 89.6% | $799.0M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OGN // BETA —
UNH // BETA 0.33